Perkins Capital Management’s DarioHealth DRIO Stock Holding History

Perkins Capital Management’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,687	Closed	-$327K	–	115
2019 Q3	$327K	Hold	2,687	–	–	0.28%	80
2019 Q2	$500K	Buy	2,687 +2,083	+345%	+$540K	0.35%	79
2019 Q1	$178K	Buy	+604	New	+$179K	0.12%	112

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Perkins Capital Management's DRIO Position: Q4 2019 in Review

Perkins Capital Management sold out of DarioHealth (DRIO) in Q4 2019, closing a stake of 2,687 shares — an estimated $327K sold.

Perkins Capital Management first reported a position in DRIO in Q1 2019 and held it in 3 quarters. The position peaked at $500K in Q2 2019. 12 funds tracked by Wall St. Rank hold DRIO as of Q4 2019.

Perkins Capital Management reported no remaining DarioHealth position as of Q4 2019 after selling out during the quarter.
Perkins Capital Management sold 2,687 DarioHealth shares in Q4 2019, an estimated $327K.
Perkins Capital Management first reported a position in DarioHealth in Q1 2019 and held it in 3 quarters.
Perkins Capital Management's DarioHealth position peaked at $500K in Q2 2019.
12 funds tracked by Wall St. Rank held DarioHealth as of Q4 2019.

Based on Perkins Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.